NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,704.00
+3.00 (0.18%)
At close: Dec 5, 2025
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 42.66 billion as of December 5, 2025. Its market cap has increased by 22.02% in one year.
Market Cap
42.66B
Enterprise Value
52.94B
Revenue
9.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,704.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 42.66B, a decrease of -86.38%. That is a compound annual growth rate of -32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 42.66B | 31.64% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | 379.90B | 21.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 684.69T |
| SK hynix | 381.13T |
| LG Energy Solution | 95.94T |
| Samsung Biologics | 76.57T |
| Hyundai Motor Company | 58.03T |
| Doosan Enerbility | 50.21T |
| KB Financial Group | 47.58T |
| HD Hyundai Heavy Industries | 47.40T |